21 / 64
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 4, July/August 2019
AFRICA
207
comprised predominantly non-calcified fibrous and fibro-fatty
plaque.
We acknowledge Dr Petra Gaylard of Data Management and Statistical
Analysis, Johannesburg, South Africa; statistical analysis by Wits Donald
Gordon Medical Centre, University of the Witwatersrand; and Ms Jacqui
de Souza (JD), Philips Volcano. This publication was made possible in part
by a grant from the Carnegie Corporation of New York. Dr Ahmed Vachiat
was supported by a Research Grant from the Carnegie Foundation. The
statements made and views expressed are, however, solely the responsibility
of the authors.
References
1.
World Health Organization. 10 facts on HIV/AIDS. Available at: http://
www.who.int/features/factfiles/hiv/facts/en/. Accessed 16 August 2017.
2.
UNAIDS. HIV and AIDS estimates (2015). Available at: http://
www.unaids.org/en/regionscountries/countries/southafrica.Accessed20
September 2017.
3.
Grinspoon SK, Grunfeld C, Kotler DP,
et al
. State of the science confer-
ence: Initiative to decrease cardiovascular risk and increase quality of
care for patients living with HIV/AIDS: executive summary.
Circulation
2008;
118
: 198–210.
4.
Currier JS, Taylor A, Boyd F,
et al
. Coronary heart disease in
HIV-infected individuals.
J Acquir Immune Defic Syndr
2003;
33
:
506–512.
5.
Klein DB, Leyden WA, Xu L,
et al
. Declining relative risk for myocar-
dial infarction among HIV-positive compared with HIV-negative indi-
viduals with access to care.
Clin Infect Dis
2015;
60
: 1278–1280.
6.
Triant VA, Lee H, Hadigan C,
et al
. Increased acute myocardial infarc-
tion rates and cardiovascular risk factors among patients with human
immunodeficiency virus disease.
J Clin Endocrin Metab
2007;
92
:
2506–2512.
7.
Lang S, Boccara F, Mary-Krause M,
et al.
Epidemiology of coronary
heart disease in HIV-infected versus uninfected individuals in developed
countries.
Arch Cardiovasc Dis
2015;
108
: 206–215.
8.
Vachiat A, McCutcheon K, Tsabedze N,
et al
. HIV and ischemic heart
disease.
J Am Coll Cardiol
2017;
69
: 73–82.
9.
Nair A, Kuban BD, Tuzcu EM,
et al
. Coronary plaque classification
with intravascular ultrasound radiofrequency data analysis.
Circulation
2002;
106
: 2200–2206.
10. Nasu K, Tsuchikane E, Katoh O,
et al
. Accuracy of
in vivo
coronary
plaque morphology assessment: a validation study of
in vivo
virtual
histology compared with
in vitro
histopathology.
J Am Coll Cardiol
2006;
47
: 2405–2412.
11. Calvert PA, Obaid DR, O’Sullivan M,
et al
. Association between IVUS
findings and adverse outcomes in patients with coronary artery disease:
the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study.
J Am Coll
Cardiol Cardiovasc Imaging
2011;
4
: 894–901.
12. Tabib A, Leroux C, Mornex JF,
et al.
Accelerated coronary atheroscle-
rosis and arteriosclerosis in young human-immunodeficiency-virus-
positive patients.
Coron Artery Dis
2000;
11
: 41–46.
13. Paton P, Tabib A, Loire R,
et al
. Coronary artery lesions and human
immunodeficiency virus infection.
Res Virol
1993;
144
: 225–231.
14. Lo J, Abbara S, Shturman L,
et al
. Increased prevalence of subclinical
coronary atherosclerosis detected by coronary computed tomography
angiography in HIV-infected men.
AIDS
2010;
24
: 243–253.
15. O’Dwyer EJ, Bhamra-Ariza P, Rao S,
et al
. Lower coronary plaque
burden in patients with HIV presenting with acute coronary syndrome.
Open Heart
2016;
3
: e000511.
16. D’Ascenzo F, Cerrato E, Calcagno A,
et al
. High prevalence at comput-
ed coronary tomography of non-calcified plaques in asymptomatic HIV
patients treated with HAART: a meta-analysis.
Atherosclerosis
2015;
240
: 197–204.
17. Stein JH, Currier JS, Hsue PY. Arterial disease in patients with human
immunodeficiency virus infection: what has imaging taught us?
J Am
Coll Cardiol Cardiovasc Imaging
2014;
7
: 515–525.
18. Fitch KV, Srinivasa S, Abbara S,
et al
. Noncalcified coronary athero-
sclerotic plaque and immune activation in HIV-infected women.
J Infect
Dis
2013;
208
: 1737–1746.
19. Kral BG, Becker LC, Vaidya D,
et al
. Noncalcified coronary plaque
volumes in healthy people with a family history of early onset coronary
artery disease.
Circ Cardiovasc Imaging
2014;
7
: 446–453.
20. El-Sadr WM, Lundgren J, Neaton JD,
et al
. Strategies for Management
of Antiretroviral Therapy (SMART) study group. CD4
+
count-guided
interruption of antiretroviral treatment.
N Engl J Med
2006;
355
:
2283–2296.
21. Kearns A, Gordon J, Burdo TH,
et al
. HIV-1-associated atherosclerosis:
unraveling the missing link.
J Am Coll Cardiol
2017;
69
: 3084–3098.
22. Hauguel-Moreau M, Boccara F, Boyd A,
et al
. Platelet reactivity in
human immunodeficiency virus infected patients on dual antiplatelet
therapy for an acute coronary syndrome: the EVERE2ST-HIV study.
Eur Heart J
2017;
38
: 1676–1686.
23. Post WS, Budoff M, Kingsley L,
et al
. Associations between HIV infec-
tion and subclinical coronary atherosclerosis.
Ann Intern Med
2014;
160
:
458–467.
24. Ahmadi N, Nabavi V, Hajsadeghi F,
et al
. Mortality incidence of
patients with non-obstructive coronary artery disease diagnosed by
computed tomography angiography.
Am J Cardiol
2011;
107
: 10–16.
25. Becker AC, Sliwa K, Stewart S,
et al
. Acute coronary syndromes in
treatment-naive black South africans with human immunodeficiency
virus infection.
J Interv Cardiol
2010;
23
: 70–77.
26. Ambrose JA, Gould RB, Kurian DC,
et al
. Frequency of and outcome
of acute coronary syndromes in patients with human immunodeficiency
virus infection.
Am J Cardiol
2003;
92
: 301–303.
27. Hsue PY, Giri K, Erickson S,
et al
. Clinical features of acute coronary
syndromes in patients with human immunodeficiency virus infection.
Circulation
2004;
109
: 316–319.
28. Boccara F, Mary-Krause M, Teiger E,
et al
. Acute coronary syndrome
in human immunodeficiency virus-infected patients: characteristics and
1 year prognosis.
Eur Heart J
2011;
32
: 41–50.
29. Freiberg MS, Chang CC, Kuller LH,
et al
. HIV infection and the risk
of acute myocardial infarction.
J Am Med Assoc Intern Med
2013;
173
:
614–622.
30. Crane HM, Paramsothy P, Drozd DR,
et al
. Types of myocardial infarc-
tion among human immunodeficiency virus-infected individuals in the
United States.
J Am Med Assoc Cardiol
2017;
2
: 260–267.